Login / Signup

Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis.

Satohiro MatsumotoHaruka OtakeMasanari SekineTakeshi UeharaHiroyuki MiyataniHirosato Mashima
Published in: Clinical drug investigation (2019)
It seems preferable to discontinue tacrolimus after endoscopic confirmation of mucosal healing. However, attention should be paid to the potential occurrence of adverse reactions associated with long-term tacrolimus therapy.
Keyphrases
  • ulcerative colitis
  • risk assessment
  • working memory
  • ultrasound guided
  • emergency department
  • human health
  • mesenchymal stem cells
  • climate change
  • drug induced